Transcatheter aortic valve implantation (TAVI) is an established treatment for inoperable patients or patients at high risk for surgery. Despite growing experience, issues remain associated with first-generation TAVI devices,
1. Groupe CardioVasculaire Interventionnel, Clinique Pasteur, Toulouse, France; 2. Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleUnmet clinical needs in transcatheter mitral valve interventions in 2014